(RTTNews) - X4 Pharmaceuticals (XFOR) posted a net loss of $36.7 million for the third quarter ended September 30, 2024, compared to a net loss of $2.3 million for the comparable period in 2023. Net ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback